AQR Capital Management’s Insmed INSM Stock Holding History

AQR Capital Management’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$109M	Buy	675,485 +207,225	+44%	+$31.9M	0.05%	491
2025 Q4	$81.5M	Buy	468,260 +180,974	+63%	+$33M	0.04%	533
2025 Q3	$40.9M	Buy	287,286 +237,571	+478%	+$29.1M	0.03%	655
2025 Q2	$5M	Sell	49,715 -1,524	-3%	-$117K	﹤0.01%	1290
2025 Q1	$3.91M	Sell	51,239 -12,932	-20%	-$989K	﹤0.01%	1250
2024 Q4	$4.43M	Buy	64,171 +1,291	+2%	+$93K	0.01%	1154
2024 Q3	$4.59M	Buy	62,880 +2,353	+4%	+$174K	0.01%	1099
2024 Q2	$4.06M	Buy	60,527 +22,616	+60%	+$877K	0.01%	1112
2024 Q1	$1.03M	Buy	37,911 +1,486	+4%	+$41.6K	﹤0.01%	1677
2023 Q4	$1.13M	Buy	36,425 +4,454	+14%	+$115K	﹤0.01%	1557
2023 Q3	$807K	Sell	31,971 -1,543	-5%	-$35.3K	﹤0.01%	1676
2023 Q2	$707K	Sell	33,514 -532	-2%	-$10.1K	﹤0.01%	1692
2023 Q1	$580K	Sell	34,046 -578	-2%	-$11.2K	﹤0.01%	1728
2022 Q4	$692K	Buy	34,624 +6,726	+24%	+$130K	﹤0.01%	1695
2022 Q3	$601K	Buy	27,898 +19	+0.1%	+$456	﹤0.01%	1705
2022 Q2	$550K	Sell	27,879 -674	-2%	-$14.1K	﹤0.01%	1650
2022 Q1	$671K	Hold	28,553	–	–	﹤0.01%	1703
2021 Q4	$778K	Hold	28,553	–	–	﹤0.01%	1668
2021 Q3	$786K	Hold	28,553	–	–	﹤0.01%	1665
2021 Q2	$813K	Sell	28,553 -20,757	-42%	-$616K	﹤0.01%	1671
2021 Q1	$1.68M	Hold	49,310	–	–	﹤0.01%	1308
2020 Q4	$1.64M	Sell	49,310 -10,084	-17%	-$368K	﹤0.01%	1266
2020 Q3	$1.91M	Buy	59,394 +8,318	+16%	+$239K	﹤0.01%	1136
2020 Q2	$1.41M	Sell	51,076 -3,025	-6%	-$71.7K	﹤0.01%	1319
2020 Q1	$867K	Sell	54,101 -15,974	-23%	-$379K	﹤0.01%	1403
2019 Q4	$1.67M	Sell	70,075 -11,281	-14%	-$229K	﹤0.01%	1332
2019 Q3	$1.44M	Sell	81,356 -5,842	-7%	-$113K	﹤0.01%	1403
2019 Q2	$2.23M	Buy	87,198 +5,734	+7%	+$160K	﹤0.01%	1229
2019 Q1	$2.37M	Buy	81,464 +7,743	+11%	+$201K	﹤0.01%	1251
2018 Q4	$967K	Sell	73,721 -29,655	-29%	-$473K	﹤0.01%	1529
2018 Q3	$2.09M	Buy	103,376 +4,373	+4%	+$98.7K	﹤0.01%	1380
2018 Q2	$2.34M	Hold	99,003	–	–	﹤0.01%	1356
2018 Q1	$2.23M	Buy	99,003 +3,071	+3%	+$80.8K	﹤0.01%	1308
2017 Q4	$2.99M	Buy	95,932 +15,756	+20%	+$465K	﹤0.01%	1209
2017 Q3	$2.5M	Buy	80,176 +67,311	+523%	+$1.28M	﹤0.01%	1298
2017 Q2	$221K	Buy	12,865 +515	+4%	+$8.8K	﹤0.01%	2101
2017 Q1	$216K	Hold	12,350	–	–	﹤0.01%	2092
2016 Q4	$163K	Hold	12,350	–	–	﹤0.01%	2176
2016 Q3	$179K	Sell	12,350 -1,010	-8%	-$12.6K	﹤0.01%	2177
2016 Q2	$132K	Hold	13,360	–	–	﹤0.01%	2148
2016 Q1	$169K	Sell	13,360 -21,447	-62%	-$282K	﹤0.01%	2133
2015 Q4	$632K	Sell	34,807 -7,551	-18%	-$133K	﹤0.01%	1774
2015 Q3	$787K	Buy	42,358 +13,038	+44%	+$325K	﹤0.01%	1554
2015 Q2	$716K	Buy	+29,320	New	+$666K	﹤0.01%	1650
2014 Q4	–	Sell	-31,090	Closed	-$406K	–	2561
2014 Q3	$406K	Hold	31,090	–	–	﹤0.01%	2030
2014 Q2	$621K	Sell	31,090 -25,800	-45%	-$382K	﹤0.01%	1890
2014 Q1	$1.08M	Hold	56,890	–	–	﹤0.01%	1663
2013 Q4	$968K	Hold	56,890	–	–	﹤0.01%	1751
2013 Q3	$888K	Hold	56,890	–	–	﹤0.01%	1718
2013 Q2	$680K	Buy	+56,890	New	+$581K	﹤0.01%	1756

Other funds holding INSM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

AQR Capital Management's INSM Position: Q1 2026 in Review

AQR Capital Management increased its Insmed (INSM) stake by 44% in Q1 2026, buying an estimated $31.9M and bringing the position to 675,485 shares worth $109M. The position accounts for 0.05% of the portfolio, ranked #491.

AQR Capital Management first reported a position in INSM in Q2 2013 and has held it in 50 quarters since. 669 funds tracked by Wall St. Rank hold INSM as of Q1 2026.

AQR Capital Management held 675,485 shares of Insmed worth $109M as of Q1 2026.
AQR Capital Management bought 207,225 Insmed shares in Q1 2026, an estimated $31.9M.
Insmed made up 0.05% of AQR Capital Management's portfolio in Q1 2026, its #491 holding.
AQR Capital Management first reported a position in Insmed in Q2 2013 and has held it in 50 quarters since.
669 funds tracked by Wall St. Rank held Insmed as of Q1 2026.

Based on AQR Capital Management's 13F filing for Q1 2026, filed 15 May 2026.